| Reporter | TradeFlow | ProductCode | Product Description | Year | Partner | Trade Value 1000USD | Quantity | Quantity Unit |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | World | 87,644.54 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | United States | 44,965.64 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | France | 11,989.59 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Mexico | 6,149.31 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Korea, Rep. | 3,452.99 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Belgium | 3,345.23 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | China | 3,273.21 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Australia | 3,038.45 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Italy | 2,964.04 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | South Africa | 1,233.24 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Thailand | 1,164.61 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Philippines | 694.07 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Other Asia, nes | 626.10 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Israel | 617.71 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Saudi Arabia | 597.87 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Colombia | 494.80 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Argentina | 325.04 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | United Kingdom | 272.96 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Peru | 271.65 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Ireland | 156.35 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Panama | 151.15 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Sweden | 150.67 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Netherlands | 149.17 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Ecuador | 142.25 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Singapore | 133.17 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Spain | 123.82 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | United Arab Emirates | 96.75 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Hong Kong, China | 81.49 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Portugal | 77.51 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Guatemala | 76.77 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | New Zealand | 65.85 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Dominican Republic | 59.76 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Jordan | 52.61 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Barbados | 51.41 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Uruguay | 44.53 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Kuwait | 42.25 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Qatar | 41.98 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Chile | 40.06 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Japan | 37.13 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Luxembourg | 33.61 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Serbia, FR(Serbia/Montenegro) | 32.64 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Switzerland | 31.41 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Costa Rica | 27.29 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Jamaica | 23.21 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Belize | 22.60 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Bermuda | 21.78 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Trinidad and Tobago | 20.42 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Venezuela | 18.49 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Bahrain | 18.12 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Malaysia | 15.97 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Bahamas, The | 15.46 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | St. Lucia | 12.62 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Lebanon | 12.17 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Norway | 12.03 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Haiti | 11.38 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Antigua and Barbuda | 10.43 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Mauritius | 10.36 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Oman | 9.88 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Bangladesh | 8.55 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Paraguay | 7.38 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Senegal | 7.01 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | St. Kitts and Nevis | 5.73 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Aruba | 3.10 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Curaçao | 1.60 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Dominica | 0.09 | | |
| Canada | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Anguila | 0.04 | | |
